Search for
Bone Marrow Aspiration - slide for review
Anemia
Report in 72Hrs
At Home
No Fasting Required
Details
Cytological review of aspirated bone marrow smear.
₹1,070₹1,529
30% OFF
Bone Marrow Aspiration - Slide for Review
- Why is it done?
- Test Purpose: Bone marrow aspiration obtains a liquid sample of bone marrow cells from the iliac crest or sternum. The aspirated sample is spread on glass slides for microscopic examination to evaluate cell morphology, maturation, and abnormalities.
- Primary Indications: Diagnosis of hematologic malignancies (leukemias, lymphomas, myelomas); evaluation of unexplained anemia, thrombocytopenia, or leukopenia; assessment of bone marrow failure syndromes; investigation of fever of unknown origin; monitoring therapeutic response in hematologic disorders; staging of lymphomas and other cancers; evaluation of pancytopenia
- Typical Timing: Performed when peripheral blood smear findings are abnormal or inconclusive; during initial diagnosis of suspected hematologic disease; during treatment follow-up of known blood disorders; when bone marrow biopsy tissue is obtained for concurrent histopathological examination
- Normal Range
- Normal Cell Proportions (Differential): Myeloid cells: 60-80%; Erythroid cells: 15-25%; Lymphocytes: 5-15%; Monocytes: 2-8%; Megakaryocytes: 0.1-0.5% (per 100 nucleated cells)
- Myeloid-to-Erythroid Ratio (M:E): Normal range: 2:1 to 4:1. Indicates balance between white and red blood cell production.
- Cellularity: Normal marrow is normocellular (50-75% cellularity). Age-adjusted: decreases with advancing age.
- Maturation Pattern: Orderly progression of cell maturation from blast forms to mature cells. No dysplasia or abnormal morphology. Adequate iron stores.
- Interpretation of Results: Normal findings indicate normal bone marrow function with adequate hematopoiesis. Abnormal findings may indicate malignancy, infection, aplasia, dysplasia, or metabolic disorders.
- Interpretation
- Leukemia Findings: Increased blasts (>20% indicates leukemia); abnormal blast morphology; immature cell predominance; disrupted normal maturation. Classification into acute vs. chronic, type (AML, ALL, CLL, CML) determined by cytochemistry and immunophenotyping.
- Aplastic Anemia: Hypocellular or acellular marrow (<10% cellularity); reduced myeloid, erythroid, and megakaryocytic elements; lymphocyte relative increase
- Myelodysplastic Syndrome (MDS): Dysplastic changes in one or more cell lines; abnormal maturation; occasional increased blasts (5-19%); cytopenia despite variable cellularity
- Hypercellular Marrow: (>75% cellularity) Indicates increased hematopoiesis; seen in response to anemia, chronic hemolysis, polycythemia, chronic infections, or proliferative disorders
- Iron Stores: Decreased iron suggests iron deficiency; increased iron indicates iron overload or sideroblastic anemia
- Infection or Infiltration: Granulomas suggest tuberculosis or fungal infection; abnormal cells indicate metastatic disease, lymphoma infiltration, or myeloma
- Factors Affecting Interpretation: Recent chemotherapy or transfusions; medications; specimen quality and preparation; sampling error; need for concurrent flow cytometry and cytochemistry for accurate diagnosis
- Associated Organs
- Primary Organ System: Hematopoietic system; bone marrow residing in flat bones (pelvis, sternum, ribs) and long bone metaphysis
- Related Conditions - Hematologic: Acute myeloid leukemia (AML); acute lymphoblastic leukemia (ALL); chronic myeloid leukemia (CML); chronic lymphocytic leukemia (CLL); multiple myeloma; lymphomas; polycythemia vera; essential thrombocythemia; primary myelofibrosis; myelodysplastic syndromes; aplastic anemia; hemolytic anemia
- Related Conditions - Infectious: Tuberculosis; fungal infections; mycobacterial infections; bacterial sepsis; viral infections affecting bone marrow
- Related Conditions - Systemic: Sarcoidosis; systemic lupus erythematosus; metastatic cancer; lipidosis; metabolic disorders affecting marrow
- Potential Complications of Abnormal Results: Severe anemia leading to tissue hypoxia; bleeding complications from thrombocytopenia; infections from leukopenia; disease progression of malignancy if not treated; organ dysfunction from infiltration; metabolic complications from bone marrow failure
- Follow-up Tests
- Concurrent Testing: Flow cytometry for immunophenotyping; cytochemical stains (MPO, PAS, SBB); bone marrow biopsy for histology; cytogenetics and FISH; molecular testing for gene mutations
- Complementary Tests: Complete blood count (CBC); peripheral blood smear; coagulation studies; biochemistry panel; lactate dehydrogenase; uric acid; immunoglobulin levels
- Staging and Further Investigation: Imaging studies (CT, PET-CT) for malignancy staging; spinal fluid examination for CNS involvement; lymph node biopsy; organ function tests
- Monitoring Frequency: During active treatment: every 4-8 weeks initially; for remission monitoring: every 3-6 months; for aplastic anemia: monthly during treatment, then quarterly; for MDS: every 3 months; for stable chronic conditions: at least annually
- Treatment Response Monitoring: Post-chemotherapy aspiration to assess for leukemic burden reduction; evaluation of cytopenia recovery; minimal residual disease detection by flow cytometry
- Fasting Required?
- Fasting Requirement: NO - Fasting is not required for bone marrow aspiration
- Pre-Procedure Preparation: Patient may eat and drink normally; light meal or snack is permissible before procedure; maintain normal hydration
- Medication Management: Continue regular medications unless instructed otherwise; warfarin or antiplatelet agents may need to be held 3-5 days prior (consult with physician); aspirin should be discontinued 5-7 days before procedure
- General Instructions: Wear comfortable clothing; arrange transportation as procedure involves local anesthesia/conscious sedation; inform provider of allergies, especially to lidocaine or other anesthetics; arrive 15-30 minutes early for registration; bladder may need to be emptied before procedure
- Post-Procedure: Can eat and drink immediately after procedure; resume all regular medications as prescribed; avoid strenuous activity for 24 hours; keep puncture site clean and dry
How our test process works!

